How can we recognize "disease modification" effects?

J Nutr Health Aging. 2009 Apr;13(4):341-3. doi: 10.1007/s12603-009-0036-7.
No abstract available

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / physiopathology
  • Biomarkers / analysis*
  • Clinical Trials as Topic
  • Humans
  • Treatment Outcome

Substances

  • Biomarkers